Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WTAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ERLEC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | FAM124B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TCTN3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SPATA5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | OLFM3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TDRKH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | AC023283.1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |